AGL

Agilon Health INC

-$132.7M

Net Activity

Institutions Holding

100

Popularity Rank

#4442

Avg Weight

0.10%

Total Value

$123.4M

Ownership Trend

100 institutions currently hold AGL, with 92 net buyers and 193 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Decreased

Based on recent trading activity

Net Selling Institutions

193

Net Buying Institutions

92

Key Holders

View all 100 holding institutions

Quarterly Activity

Recent Activity

+$114.6M

Total Buy Value

$73.5B

Total Sell Value

New buy92
Trim4
Add0
Sold out189

92

Net Buyers

193

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding AGILON HEALTH INC (AGL)?
Major stakeholders currently include Clayton, Dubilier & Rice, LLC ($31.6M), Morgan Stanley ($16.6M), North Peak Capital Management, LLC ($12.2M). Based on the latest 13F filings, there are a total of 100 tracked investment funds and institutions maintaining positions in AGL.
What is the overall institutional sentiment toward AGL recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $132.7M, driven by 92 managers accumulating shares while 193 reduced their exposure.
Which institutions have been selling or reducing their AGL positions?
In the latest period, 4 funds trimmed their holdings, and 189 managers completely exited their positions. The aggregate reported sell value was $73.5B.
Are there any notable investors adding AGL to their portfolios?
Yes, buying activity remains notable. 92 institutions opened new positions in {ticker}, and 0 existing holders added to their shares. The total reported buy value for the quarter amounted to $114.6M.

Related Stocks